The Emails
From: Badkar, Advalt V <advat.v
[email protected]>
Sent: Thursday, February 4, 2021 1:26 PM
To: Dormitzer, Pip Ralph «Philp. Dormitzer@pfizer. com>; Swanson, Kena Anne
kena
[email protected]>
‘Subject: FW: Medical Information enquiry regarding COVID-19 mANA Vaccine BNT16262
Hithere,
assume the answer to the question In “bol” below is NO. Can you confirm?
Thanks,
Aat
mageoo7 pne>
From: Qureshi, Ambereen <
[email protected]>
Sent: Wednesday, February 3, 2021 8:11 AM
To: Weiser, Sarah Elizabeth «Sarah Welzer@pfzercom>
Ce: Barras Ana <
[email protected]>
Subject: Medical Information enquiry regarding COVIO-19 mRNA Vaccine BNT16262
Dear sarah,
"hope that you ae well
have received an enquly as follows:
“did Pfizer make use of cell line from an aborted foetus when carrying out any confirmatory tests for
this vaccine?”
We have already confirmed with the customer that no 001 ines from an aborted foetus were used in the
manufacturing process of the COVID-19 mRNA Vaccine BNT16262.
Do we have any information to provide in response to her question?